Skip to main content
Clinical Trials/NCT02937376
NCT02937376UnknownEarly Phase 1

Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise

University of Thessaly1 site in 1 country12 target enrollmentStarted: February 1, 2023Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Early Phase 1
Enrollment
12
Locations
1
Primary Endpoint
Change in redox status after exercise

Study Overview

Brief Summary

The purpose of this study is to investigate the effects of N-acetyl Cystein (NAC) supplementation on redox status, physiological and biochemical parameters in G6PD deficient individuals after acute exercise.

Detailed Description

In a randomized double-blind, crossover design, 12 adult volunteers with G6PD deficiency of both sexes will be supplemented with either 10 mg/kg of NAC (experimental condition - EC) or placebo (control condition - CC) every day for 4 weeks. Before intervention, all participants will be informed about the study protocol, fill a medical history questionnaire and sign an informed consent form. Moreover, measurements of anthropometric characteristics and physiological parameters, as well as a VO2max test will be performed.

Participants will perform 4 trials of exercise (70% VO2max for 45min and 90% till exhaustion) before and after each condition. Blood samples will be collected before, immediately after and 1 hour after exercise. Moreover, measurements of anthropometric characteristics and physiological parameters will be performed before and after each condition. There will be a washout period of at 4 weeks between conditions.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • G6PD deficiency

Exclusion Criteria

  • Any uncontrolled health condition for which exercise is contraindicated
  • Current use of dietary supplements or drugs
  • Pregnant, pregnancy intention or breast feeding

Arms & Interventions

N-acetyl Cystein

Experimental

NAC supplementation (10 mg/kg/day) for 4 weeks in a counterbalanced manner to 12 G6PD deficient individuals.

Intervention: N-acetyl cystein (Drug)

Placebo

Placebo Comparator

Placebo administration for 4 weeks in a counterbalanced manner to 12 G6PD deficient individuals.

Intervention: Placebo (Other)

Outcomes

Primary Outcomes

Change in redox status after exercise

Time Frame: Before, immediately after and 1 hour after each trial of exercise

Indices of blood redox status

Secondary Outcomes

  • Body composition(Before and after 4 weeks of NAC supplementation, before and after 4 weeks of placebo)
  • Blood pressure(Before and after 4 weeks of NAC supplementation, before and after 4 weeks of placebo)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Athanasios Z. Jamurtas

Professor

University of Thessaly

Study Sites (1)

Loading locations...

Similar Trials

Effects of N-acetyl Cystein (NAC)... | Clinical Trial